Elsevier

Homeopathy

Volume 91, Issue 4, October 2002, Pages 197-206
Homeopathy

Original Paper
Does a homeopathic ultramolecular dilution of Thyroidinum 30cH affect the rate of body weight reduction in fasting patients? A randomised placebo-controlled double-blind clinical trial

https://doi.org/10.1054/homp.2002.0049Get rights and content

Abstract

Objective: To test whether an ultramolecular dilution of homeopathic Thyroidinum has an effect over placebo on weight reduction of fasting patients in so-called ‘fasting crisis’.

Design: Randomised, placebo-controlled, double-blind, parallel group, monocentre study.

Setting/location: Hospital for internal and complementary medicine in Munich, Germany.

Subjects: Two hundred and eight fasting patients encountering a stagnation or increase of weight after a weight reduction of at least 100 g/day in the preceding 3 days.

Intervention: One oral dose ofThyroidinum 30cH (preparation of thyroid gland) or placebo.

Outcome Measures: Main outcome measure was reduction of body weight 2 days after treatment. Secondary outcome measures were weight reduction on days 1 and 3, 15 complaints on days 1–3, and 34 laboratory findings on days 1–2 after treatment.

Results: Weight reduction on the second day after medication in the Thyroidinum group was less than in the placebo group (mean difference 92 g, 95% confidence interval 7–176 g, P=0.034). Adjustment for baseline differences in body weight and rate of weight reduction before medication, however, weakened the result to a non-significant level (P=0.094). There were no differences between groups in the secondary outcome measures.

Conclusions: Patients receiving Thyroidinum had less weight reduction on day 2 after treatment than those receiving placebo. Yet, since no significant differences were found in other outcomes and since adjustment for baseline differences rendered the difference for the main outcome measure non-significant, this result must be interpreted with caution. Post hoc evaluation of the data, however, suggests that by predefining the primary outcome measure in a different way, an augmented reduction of weight on day 1 after treatment with Thyroidinum may be demonstrated. Both results would be compatible with homeopathic doctrine (primary and secondary effect) as well as with findings from animal research.

References (50)

  • DG Altman et al.

    Randomisation and baseline comparisons in clinical trials

    Lancet

    (1990)
  • SF Assmann et al.

    Subgroup analysis and other (mis)uses of baseline data in clinical trials

    Lancet

    (2000)
  • J Kleijnen et al.

    Clinical trials of homoeopathy

    BMJ

    (1991)
  • H Walach et al.

    Classical homoeopathic treatment of chronic headaches. A double-blind, randomized, placebo-controlled study

    Cephalgia

    (1997)
  • SF Beer et al.

    The effect of a 72-h fast on plasma levels of pituitary, adrenal, thyroid, pancreatic and gastrointestinal hormones in healthy men and women

    J Endocrinol

    (1989)
  • JA Romijn et al.

    Pulsatile secretion of thyrotropin during fasting: a decrease of thyrotropin pulse amplitude

    J Clin Endocrinol Metab

    (1990)
  • DF Gardner et al.

    Effect of tri-iodothyronine replacement on the metabolic and pituitary responses to starvation

    N Engl J Med

    (1979)
  • HP Koppeschaar et al.

    Metabolic responses during modified fasting and refeeding: the role of sympathetic nervous system activity and thyroid hormones

    Hum Nutr Clin Nutr

    (1985)
  • ME Everts et al.

    Different regulation of thyroid hormone transport in liver and pituitary: its possible role in the maintenance of low T3 production during nonthyroidal illness and fasting in man

    Thyroid

    (1996)
  • LO Byerley et al.

    Metabolic effects of triiodothyronine replacement during fasting in obese subjects

    J Clin Endocrinol Metab

    (1996)
  • NL Geller et al.

    Interim analyses in randomized clinical trials: ramifications and guidlines for practitioners

    Biometrics

    (1987)
  • K KG Lan et al.

    Stochastically curtailed tests in long-term clinical trials

    Commun Statist

    (1982)
  • PC Endler et al.

    Effects of highly diluted succussed thyroxine on metamorphosis of highland frogs

    Berlin J Res Homoeopathy

    (1991)
  • PC Endler et al.

    Controversies in toxicology: non-molecular information transfer from thyroxine to frogs with regard to homeopathic toxicology

    Vet Hum Toxicol

    (1995)
  • Cited by (0)

    *

    Josef M Schmidt, Krankenhaus für Naturheilweisen, Sanatoriumsplatz 2, D-81545 München, Germany. E-mail: [email protected]

    View full text